%PDF-1.6
%
1 0 obj
<>
endobj
2 0 obj
<>stream
Song Ren, Ying Wang, Li Xian, Tadashi Toyama, Meg Jardine, Guisen Li, Vlado Perkovic, Daqing Hong
Comparative effectiveness and tolerance of immunosuppressive treatments for idiopathic membranous nephropathy: A network meta-analysis
www.plosone.org
www.plosone.org
endstream
endobj
3 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 12 0 R/Annots 13 0 R/Contents 14 0 R/TrimBox[0 0 612 792]>>
endobj
13 0 obj
[15 0 R 16 0 R 17 0 R 18 0 R 19 0 R 20 0 R 21 0 R 22 0 R 23 0 R 24 0 R]
endobj
15 0 obj
<>/Border[0 0 0]/Dest(Rpone.0184398.ref001)>>
endobj
16 0 obj
<>/Border[0 0 0]/Dest(Rpone.0184398.ref002)>>
endobj
17 0 obj
<>/Border[0 0 0]/Dest(Rpone.0184398.ref003)>>
endobj
18 0 obj
<>/Border[0 0 0]/Dest(Rpone.0184398.ref004)>>
endobj
19 0 obj
<>/Border[0 0 0]/Dest(Rpone.0184398.ref005)>>
endobj
20 0 obj
<>/Border[0 0 0]/Dest(Rpone.0184398.s009)>>
endobj
21 0 obj
<>/Border[0 0 0]/A 25 0 R>>
endobj
25 0 obj
<>
endobj
22 0 obj
<>/Border[0 0 0]/A 26 0 R>>
endobj
26 0 obj
<>
endobj
23 0 obj
<>/Border[0 0 0]/A 27 0 R>>
endobj
27 0 obj
<>
endobj
24 0 obj
<>/Border[0 0 0]/A 28 0 R>>
endobj
28 0 obj
<>
endobj
14 0 obj
[29 0 R 30 0 R 31 0 R 32 0 R 33 0 R 34 0 R 35 0 R 36 0 R 37 0 R 38 0 R]
endobj
29 0 obj
<>stream
q
0.45 0.36 0.35 0.01 k
0 w
575.9997 520.4863 m
199.9998 520.4863 l
199.9998 520.9863 l
575.9997 520.9863 l
f*
0.83 0.64 0.02 0 k
323.263 433.6441 m
328.0252 433.6441 l
h
f*
316.6299 381.6567 m
321.3354 381.6567 l
h
f*
323.6031 381.6567 m
328.3654 381.6567 l
h
f*
346.0535 355.6913 m
350.8157 355.6913 l
h
f*
486.9921 303.6472 m
491.7543 303.6472 l
h
f*
203.4142 107.9433 m
239.0173 107.9433 l
h
f*
398.778 107.9433 m
505.5874 107.9433 l
h
f*
527.3575 107.9433 m
550.2047 107.9433 l
h
f*
200.0126 94.9039 m
264.8693 94.9039 l
h
f*
0 g
1 j
1 J
9.5 0 0 9.5 200.0125 707.7543 cm
BT
/F0 1 Tf
1 TL
-0.0042 Tc
0 0 Td
(did)Tj
1.5336 0 Td
(not)Tj
1.5934 0 Td
(\(OR)Tj
2.0409 0 Td
(=)Tj
0.7997 0 Td
(1.58,)Tj
2.4229 0 Td
(95%CI:)Tj
3.4731 0 Td
(0.803.12\))Tj
4.9413 0 Td
(as)Tj
1.2651 0 Td
(compared)Tj
4.6249 0 Td
(with)Tj
1.9753 0 Td
(non-immunosuppress)Tj
9.5125 0 Td
(ive)Tj
1.48 0 Td
(treat-)Tj
-35.6627 -1.474 Td
(ment.)Tj
2.7033 0 Td
(Chlorambucil)Tj
5.9796 0 Td
(also)Tj
2.029 0 Td
(significantly)Tj
5.3172 0 Td
(increased)Tj
4.4996 0 Td
(the)Tj
1.5993 0 Td
(withdrawal)Tj
4.8816 0 Td
(risk)Tj
1.7544 0 Td
(\(OR)Tj
2.047 0 Td
(=)Tj
0.7996 0 Td
(3.34,)Tj
2.4229 0 Td
(95%CI:)Tj
-34.0335 -1.474 Td
(1.378.17\))Tj
4.9471 0 Td
(as)Tj
1.2652 0 Td
(compared)Tj
4.6189 0 Td
(to)Tj
1.0444 0 Td
(CTX.)Tj
2.4885 0 Td
(Both)Tj
2.2558 0 Td
(tacrolimus)Tj
4.7264 0 Td
(\(OR)Tj
2.0469 0 Td
(=)Tj
0.7996 0 Td
(3.10,)Tj
2.4229 0 Td
(95%CI:)Tj
3.4672 0 Td
(1.367.09\))Tj
4.9472 0 Td
(and)Tj
1.8679 0 Td
(cyclo-)Tj
-36.898 -1.474 Td
(sporine)Tj
3.4552 0 Td
(\(CsA\))Tj
2.7571 0 Td
(\(OR)Tj
2.0409 0 Td
(=)Tj
0.7997 0 Td
(2.81,)Tj
2.4229 0 Td
(95%CI:)Tj
3.4672 0 Td
(1.087.32\))Tj
4.9471 0 Td
(also)Tj
2.029 0 Td
(significantly)Tj
5.3172 0 Td
(increased)Tj
4.5056 0 Td
(the)Tj
1.5934 0 Td
(rate)Tj
1.9216 0 Td
(of)Tj
1.0503 0 Td
(CR)Tj
1.647 0 Td
(or)Tj
-37.9542 -1.474 Td
(PR)Tj
1.5993 0 Td
(as)Tj
1.2651 0 Td
(compared)Tj
4.619 0 Td
(with)Tj
1.9753 0 Td
(non-immunos)Tj
5.9975 0 Td
(uppressive)Tj
4.9949 0 Td
(treatment)Tj
4.4101 0 Td
(\(without)Tj
3.682 0 Td
(significant)Tj
4.6071 0 Td
(difference)Tj
4.5593 0 Td
(as)Tj
-37.7096 -1.474 Td
(compared)Tj
4.6189 0 Td
(with)Tj
1.9753 0 Td
(CTX\),)Tj
2.8167 0 Td
(while)Tj
2.4647 0 Td
(ranking)Tj
3.4553 0 Td
(results)Tj
3.133 0 Td
(showed)Tj
3.6283 0 Td
(that)Tj
1.8739 0 Td
(cyclosporine)Tj
5.705 0 Td
(or)Tj
1.0981 0 Td
(tacrolimus)Tj
4.7264 0 Td
(was)Tj
1.9812 0 Td
(with)Tj
-37.4768 -1.474 Td
(less)Tj
1.9752 0 Td
(possibility)Tj
4.4937 0 Td
(of)Tj
1.0443 0 Td
(drug)Tj
2.1961 0 Td
(withdrawal)Tj
4.8816 0 Td
(as)Tj
1.2651 0 Td
(compared)Tj
4.6249 0 Td
(to)Tj
1.0444 0 Td
(CTX.)Tj
ET
Q
q
1 j
1 J
0 w
11.4998 0 0 11.4998 200.0125 593.0078 cm
BT
/F2 1 Tf
1 TL
-0.0035 Tc
0 0 Td
(Conclusions)Tj
ET
Q
q
1 j
1 J
0 w
9.5 0 0 9.5 200.0125 576 cm
BT
/F0 1 Tf
1 TL
-0.0042 Tc
0 0 Td
(Cyclophosphamide)Tj
8.6232 0 Td
(and)Tj
1.8679 0 Td
(chlorambucil)Tj
5.7588 0 Td
(reduce)Tj
3.2404 0 Td
(risk)Tj
1.7605 0 Td
(of)Tj
1.0443 0 Td
(ESKD)Tj
2.9242 0 Td
(or)Tj
1.098 0 Td
(death)Tj
2.6974 0 Td
(in)Tj
0.9787 0 Td
(IMN)Tj
2.0469 0 Td
(with)Tj
1.9753 0 Td
(nephrotic)Tj
-34.0156 -1.474 Td
(range)Tj
2.7451 0 Td
(proteinuria,)Tj
5.156 0 Td
(but)Tj
1.5934 0 Td
(carry)Tj
2.4229 0 Td
(substantial)Tj
4.9412 0 Td
(toxicity)Tj
3.2404 0 Td
(that)Tj
1.8739 0 Td
(may)Tj
2.0946 0 Td
(be)Tj
1.3189 0 Td
(lower)Tj
2.578 0 Td
(for)Tj
1.3725 0 Td
(cyclophospha)Tj
6.0453 0 Td
(mide.)Tj
-35.3822 -1.474 Td
(Tacrolimus)Tj
5.0605 0 Td
(and)Tj
1.8619 0 Td
(cyclosporine)Tj
5.7111 0 Td
(increase)Tj
3.9506 0 Td
(the)Tj
1.5993 0 Td
(possibility)Tj
4.4936 0 Td
(of)Tj
1.0444 0 Td
(proteinuria)Tj
4.8756 0 Td
(remission)Tj
4.4518 0 Td
(with)Tj
1.9753 0 Td
(less)Tj
1.9753 0 Td
(drug)Tj
-36.9994 -1.474 Td
(withdrawal,)Tj
5.162 0 Td
(but)Tj
1.5933 0 Td
(the)Tj
1.5934 0 Td
(effects)Tj
3.145 0 Td
(on)Tj
1.3128 0 Td
(kidney)Tj
3.0793 0 Td
(failure)Tj
2.9003 0 Td
(remain)Tj
3.2405 0 Td
(uncertain.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 464.7685 cm
BT
/F2 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Introduction)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 447.7606 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(Idiopathic)Tj
4.3256 0 Td
(membranous)Tj
5.5445 0 Td
(nephropathy)Tj
5.3461 0 Td
(\(IMN\))Tj
2.8687 0 Td
(is)Tj
0.8447 0 Td
(one)Tj
1.7008 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4683 0 Td
(commonest)Tj
4.9323 0 Td
(causes)Tj
2.7495 0 Td
(of)Tj
1.0148 0 Td
(primary)Tj
-31.8101 -1.3039 Td
(nephrotic)Tj
4.1045 0 Td
(syndrome)Tj
4.2293 0 Td
(in)Tj
1.0374 0 Td
(adults)Tj
2.6136 0 Td
([)Tj
0.83 0.64 0.02 0 k
(1)Tj
0 g
(].)Tj
1.6044 0 Td
(Approximately)Tj
6.2248 0 Td
(one-third)Tj
4.0422 0 Td
(of)Tj
1.0148 0 Td
(affected)Tj
3.3278 0 Td
(individuals)Tj
4.6488 0 Td
(will)Tj
1.6611 0 Td
(have)Tj
2.0636 0 Td
(a)Tj
-36.5723 -1.2982 Td
(complete)Tj
3.8777 0 Td
(and)Tj
1.7291 0 Td
(spontaneous)Tj
5.2554 0 Td
(remission)Tj
4.1443 0 Td
(of)Tj
1.0148 0 Td
(proteinuria,)Tj
4.9776 0 Td
(while)Tj
2.3697 0 Td
(another)Tj
3.3335 0 Td
(third)Tj
2.2111 0 Td
(develop)Tj
3.3221 0 Td
(persistent)Tj
-32.2353 -1.2983 Td
(proteinuria)Tj
4.7508 0 Td
(with)Tj
2.0012 0 Td
(long-term)Tj
4.2463 0 Td
(preservation)Tj
5.1987 0 Td
(of)Tj
1.0148 0 Td
(renal)Tj
2.245 0 Td
(function.)Tj
3.8551 0 Td
(However,)Tj
4.0762 0 Td
(the)Tj
1.4684 0 Td
(remaining)Tj
4.3653 0 Td
(third)Tj
2.211 0 Td
(of)Tj
-35.4328 -1.3039 Td
(patients)Tj
3.3675 0 Td
(will)Tj
1.6611 0 Td
(progress)Tj
3.6 0 Td
(to)Tj
1.0261 0 Td
(end-stage)Tj
4.0535 0 Td
(kidney)Tj
2.9367 0 Td
(disease)Tj
3.016 0 Td
(\(ESKD\),)Tj
3.583 0 Td
(and)Tj
1.7291 0 Td
(the)Tj
1.4684 0 Td
(risk)Tj
1.7177 0 Td
(is)Tj
0.8448 0 Td
(higher)Tj
2.8062 0 Td
(in)Tj
1.0318 0 Td
(people)Tj
2.8574 0 Td
(with)Tj
-35.6993 -1.2983 Td
(nephrotic)Tj
4.1045 0 Td
(range)Tj
2.4604 0 Td
(proteinuria)Tj
4.7566 0 Td
([)Tj
0.83 0.64 0.02 0 k
(2)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(3)Tj
0 g
(].)Tj
-10.1253 -1.2982 Td
(Overall,)Tj
3.3732 0 Td
(immunosuppressive)Tj
8.2941 0 Td
(therapy)Tj
3.2428 0 Td
(has)Tj
1.5477 0 Td
(been)Tj
2.1203 0 Td
(suggested)Tj
4.0705 0 Td
(to)Tj
1.0262 0 Td
(reduced)Tj
3.4469 0 Td
(proteinuria,)Tj
4.9776 0 Td
(all-cause)Tj
-33.2955 -1.2983 Td
(mortality)Tj
3.9174 0 Td
(and)Tj
1.7291 0 Td
(progression)Tj
4.9209 0 Td
(to)Tj
1.0262 0 Td
(ESKD)Tj
2.6702 0 Td
([)Tj
0.83 0.64 0.02 0 k
(4)Tj
0 g
(].)Tj
1.6044 0 Td
(The)Tj
1.7801 0 Td
(Kidney)Tj
3.1181 0 Td
(Disease)Tj
3.2258 0 Td
(Improving)Tj
4.5071 0 Td
(Global)Tj
2.88 0 Td
(Outcomes)Tj
-31.3793 -1.3039 Td
(\(KDIGO\))Tj
4.1102 0 Td
(guidelines)Tj
4.2802 0 Td
(recommend)Tj
5.0854 0 Td
(steroids)Tj
3.3335 0 Td
(plus)Tj
1.8708 0 Td
(alkylating)Tj
4.1103 0 Td
(agents)Tj
2.7552 0 Td
(in)Tj
1.0318 0 Td
(patients)Tj
3.3676 0 Td
(at)Tj
0.9524 0 Td
(high)Tj
2.0126 0 Td
(risk)Tj
1.7121 0 Td
(of)Tj
-34.6221 -1.2983 Td
(developing)Tj
4.5977 0 Td
(ESKD)Tj
2.6759 0 Td
(based)Tj
2.4718 0 Td
(on)Tj
1.2756 0 Td
(severe)Tj
2.6815 0 Td
(proteinuria.)Tj
4.9776 0 Td
(People)Tj
2.897 0 Td
(with)Tj
1.9956 0 Td
(contraindications)Tj
7.251 0 Td
(for)Tj
1.389 0 Td
(alkylating)Tj
-32.2127 -1.2983 Td
(agents)Tj
2.7495 0 Td
(or)Tj
1.0999 0 Td
(who)Tj
1.9389 0 Td
(do)Tj
1.2529 0 Td
(not)Tj
1.576 0 Td
(tolerant)Tj
3.3449 0 Td
(them,)Tj
2.5171 0 Td
(are)Tj
1.4457 0 Td
(recommended)Tj
6.0377 0 Td
(to)Tj
1.0262 0 Td
(receive)Tj
3.0047 0 Td
(steroids)Tj
3.3392 0 Td
(plus)Tj
1.8708 0 Td
(calcineurin)Tj
-31.2035 -1.3039 Td
(inhibitors,)Tj
4.3653 0 Td
(\(such)Tj
2.3981 0 Td
(as)Tj
1.0148 0 Td
(tacrolimus)Tj
4.4787 0 Td
(and)Tj
1.7291 0 Td
(cyclosporine\))Tj
5.6126 0 Td
(as)Tj
1.0148 0 Td
(second)Tj
3.0103 0 Td
(line)Tj
1.7065 0 Td
(therapy[)Tj
0.83 0.64 0.02 0 k
(5)Tj
0 g
(].)Tj
4.6261 0 Td
(However,)Tj
4.0762 0 Td
(the)Tj
1.474 0 Td
(qual-)Tj
-35.5065 -1.2982 Td
(ity)Tj
1.2415 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4684 0 Td
(evidence)Tj
3.7133 0 Td
(has)Tj
1.5421 0 Td
(been)Tj
2.1203 0 Td
(noted)Tj
2.5228 0 Td
(to)Tj
1.0261 0 Td
(be)Tj
1.1509 0 Td
(moderate)Tj
4.0251 0 Td
(leaving)Tj
3.0614 0 Td
(residual)Tj
3.3789 0 Td
(uncertainty)Tj
4.8132 0 Td
(about)Tj
2.4945 0 Td
(the)Tj
1.4683 0 Td
(opti-)Tj
-35.0416 -1.2983 Td
(mal)Tj
1.7177 0 Td
(treatment)Tj
4.1386 0 Td
(approach,)Tj
4.1726 0 Td
(and)Tj
1.7348 0 Td
(a)Tj
0.6519 0 Td
(number)Tj
3.4186 0 Td
(of)Tj
1.0148 0 Td
(additional)Tj
4.2746 0 Td
(randomized-control)Tj
8.0957 0 Td
(led)Tj
1.4173 0 Td
(trials)Tj
2.194 0 Td
(\(RCTs\))Tj
-32.8306 -1.3039 Td
(evaluating)Tj
4.3199 0 Td
(novel)Tj
2.3981 0 Td
(immunosuppressive)Tj
8.2941 0 Td
(therapies)Tj
3.8438 0 Td
(for)Tj
1.389 0 Td
(IMN)Tj
2.1883 0 Td
(have)Tj
2.0579 0 Td
(been)Tj
2.126 0 Td
(published)Tj
4.1216 0 Td
(subsequent)Tj
4.7054 0 Td
(to)Tj
-35.4441 -1.2983 Td
(these)Tj
2.2506 0 Td
(guidelines.)Tj
-1.0544 -1.2982 Td
(In)Tj
1.1111 0 Td
(this)Tj
1.6725 0 Td
(study,)Tj
2.6192 0 Td
(we)Tj
1.3266 0 Td
(used)Tj
2.0579 0 Td
(network)Tj
3.549 0 Td
(meta-analysis)Tj
5.6522 0 Td
(to)Tj
1.0261 0 Td
(directly)Tj
3.2315 0 Td
(and)Tj
1.7291 0 Td
(indirectly)Tj
4.0479 0 Td
(compare)Tj
3.719 0 Td
(the)Tj
1.4684 0 Td
(effects)Tj
-34.4067 -1.2983 Td
(of)Tj
1.0147 0 Td
(different)Tj
3.6567 0 Td
(immunosuppressive)Tj
8.2941 0 Td
(regimens)Tj
3.9005 0 Td
(on)Tj
1.2756 0 Td
(renal)Tj
2.2393 0 Td
(survival,)Tj
3.566 0 Td
(proteinuria)Tj
4.7508 0 Td
(remission)Tj
4.1499 0 Td
(and)Tj
1.7291 0 Td
(tolera-)Tj
-34.5767 -1.3039 Td
(bility)Tj
2.2563 0 Td
(in)Tj
1.0375 0 Td
(people)Tj
2.8573 0 Td
(with)Tj
1.9956 0 Td
(IMN)Tj
2.1883 0 Td
(and)Tj
1.7291 0 Td
(nephrotic)Tj
4.1046 0 Td
(range)Tj
2.4661 0 Td
(proteinuria.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 183.0047 cm
BT
/F2 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Materials)Tj
4.5071 0 Td
(and)Tj
1.989 0 Td
(methods)Tj
/F0 1 Tf
-6.4961 -1.5023 Td
(Data)Tj
2.3102 0 Td
(sources)Tj
3.6803 0 Td
(and)Tj
1.8662 0 Td
(searches)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 148.0251 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(The)Tj
1.7801 0 Td
(Cochrane)Tj
4.1215 0 Td
(Central)Tj
3.2032 0 Td
(Register)Tj
3.4526 0 Td
(of)Tj
1.0147 0 Td
(Controlled)Tj
4.5581 0 Td
(Trials)Tj
2.5115 0 Td
(\(CENTRAL\),)Tj
5.5502 0 Td
(MEDLINE)Tj
4.6034 0 Td
(and)Tj
1.7292 0 Td
(EMBASE)Tj
-32.5245 -1.3039 Td
(databases)Tj
3.9968 0 Td
(were)Tj
2.1259 0 Td
(systematically)Tj
5.743 0 Td
(searched)Tj
3.7077 0 Td
(for)Tj
1.389 0 Td
(randomized)Tj
5.0569 0 Td
(controlled)Tj
4.32 0 Td
(trials)Tj
2.1997 0 Td
(in)Tj
1.0375 0 Td
(people)Tj
2.8516 0 Td
(with)Tj
2.0012 0 Td
(IMN)Tj
-34.4293 -1.2982 Td
(up)Tj
1.2642 0 Td
(to)Tj
1.0261 0 Td
(May)Tj
2.0013 0 Td
(3,)Tj
0.9184 0 Td
(2016.)Tj
2.3471 0 Td
(The)Tj
1.7858 0 Td
(search)Tj
2.7609 0 Td
(terms)Tj
2.4945 0 Td
(used)Tj
2.0579 0 Td
(consisted)Tj
3.9402 0 Td
(of)Tj
1.0148 0 Td
(IMN)Tj
2.1883 0 Td
(and)Tj
1.7291 0 Td
(randomized)Tj
5.057 0 Td
(controlled)Tj
4.32 0 Td
(trials)Tj
-34.9056 -1.2983 Td
(\()Tj
0.83 0.64 0.02 0 k
/F11 1 Tf
(S1)Tj
1.5533 0 Td
(Table)Tj
0 g
/F6 1 Tf
(\).)Tj
3.1295 0 Td
(We)Tj
1.61 0 Td
(searched)Tj
3.7134 0 Td
(two)Tj
1.7064 0 Td
(additional)Tj
4.2803 0 Td
(websites)Tj
3.5433 0 Td
([)Tj
0.83 0.64 0.02 0 k
(www.controlled-trials.)Tj
9.2749 0 Td
(com)Tj
0 g
(,)Tj
2.194 0 Td
(and)Tj
0.83 0.64 0.02 0 k
1.7291 0 Td
(www.)Tj
-32.7342 -1.3039 Td
(clinicaltrials.gov)Tj
0 g
(])Tj
7.0468 0 Td
(for)Tj
1.3833 0 Td
(ongoing)Tj
3.532 0 Td
(clinical)Tj
3.0727 0 Td
(trials,)Tj
2.4265 0 Td
(and)Tj
1.7291 0 Td
(manually)Tj
3.9288 0 Td
(checked)Tj
3.4696 0 Td
(the)Tj
1.4683 0 Td
(reference)Tj
3.9175 0 Td
(lists)Tj
1.7518 0 Td
(of)Tj
-33.7264 -1.2983 Td
(included)Tj
3.7133 0 Td
(studies)Tj
2.982 0 Td
(to)Tj
1.0262 0 Td
(identify)Tj
3.2938 0 Td
(additional)Tj
4.2803 0 Td
(eligible)Tj
3.0671 0 Td
(studies.)Tj
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 107.1496 23.6976 re
W* n
q
107.0929 0 0 23.6409 36 741.3165 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 350.5322 745.7952 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(Immunos)Tj
4.0535 0 Td
(uppressive)Tj
4.9678 0 Td
(treatments)Tj
4.8756 0 Td
(for)Tj
1.3677 0 Td
(IMN:)Tj
2.3103 0 Td
(A)Tj
0.8787 0 Td
(network)Tj
3.6638 0 Td
(meta-ana)Tj
4.1528 0 Td
(lysis)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
0.83 0.64 0.02 0 k
81.5811 34.9228 m
237.8835 34.9228 l
h
f*
0 g
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(ONE)Tj
2.3669 0 Td
(|)Tj
0.83 0.64 0.02 0 k
0.4748 0 Td
(https://doi.or)Tj
5.4142 0 Td
(g/10.137)Tj
3.8198 0 Td
(1/journal.po)Tj
5.1236 0 Td
(ne.01843)Tj
4.089 0 Td
(98)Tj
0 g
2.0906 0 Td
(September)Tj
5.0386 0 Td
(12,)Tj
1.5874 0 Td
(2017)Tj
32.2798 0 Td
(2)Tj
0.7654 0 Td
(/)Tj
0.496 0 Td
(15)Tj
/F9 1 Tf
-0.025 Tc
-66.402 84.0904 Td
(supported)Tj
3.9897 0 Td
(by)Tj
1.1197 0 Td
(John)Tj
2.0623 0 Td
(Chalmers)Tj
3.7346 0 Td
(Servier)Tj
2.8205 0 Td
(Post-doc)Tj
3.3449 0 Td
(toral)Tj
-17.0717 -1.3748 Td
(fellowship)Tj
3.7346 0 Td
(.)Tj
/F8 1 Tf
-3.7346 -2.126 Td
(Competing)Tj
4.3795 0 Td
(interests)Tj
3.3307 0 Td
(:)Tj
/F9 1 Tf
0.4819 0 Td
(The)Tj
1.5875 0 Td
(authors)Tj
3.0401 0 Td
(have)Tj
1.963 0 Td
(declared)Tj
-14.7827 -1.3749 Td
(that)Tj
1.6228 0 Td
(no)Tj
1.1693 0 Td
(competing)Tj
4.1599 0 Td
(interests)Tj
ET
endstream
endobj
30 0 obj
<>stream
endstream
endobj
31 0 obj
<>stream
endstream
endobj
32 0 obj
<>stream
endstream
endobj
33 0 obj
<>stream
endstream
endobj
34 0 obj
<>stream
endstream
endobj
35 0 obj
<>stream
endstream
endobj
36 0 obj
<>stream
endstream
endobj
37 0 obj
<>stream
endstream
endobj
38 0 obj
<>stream
BT
10.3394 79.2147 Td
(exist.)Tj
ET
Q
endstream
endobj
39 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 12 0 R/Annots 42 0 R/Contents 43 0 R/TrimBox[0 0 612 792]>>
endobj
42 0 obj
[44 0 R 45 0 R 46 0 R 47 0 R]
endobj
44 0 obj
<>/Border[0 0 0]/Dest(Rpone.0184398.ref006)>>
endobj
45 0 obj
<>/Border[0 0 0]/Dest(Rpone.0184398.ref007)>>
endobj
46 0 obj
<>/Border[0 0 0]/Dest(Rpone.0184398.ref008)>>
endobj
47 0 obj
<>/Border[0 0 0]/A 48 0 R>>
endobj
48 0 obj
<>
endobj
43 0 obj
[49 0 R 50 0 R 51 0 R 52 0 R 53 0 R 54 0 R 55 0 R]
endobj
49 0 obj
<>stream
q
0.83 0.64 0.02 0 k
549.0709 326.4378 m
553.8331 326.4378 l
h
f*
317.7638 313.4551 m
322.4693 313.4551 l
h
f*
393.8457 261.4677 m
398.6079 261.4677 l
h
f*
0 g
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 706.0535 cm
BT
/F0 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Study)Tj
2.7543 0 Td
(selection)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 689.1023 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(Studies)Tj
3.101 0 Td
(of)Tj
1.0148 0 Td
(immunosuppressive)Tj
8.2942 0 Td
(treatments)Tj
4.4957 0 Td
(in)Tj
1.0374 0 Td
(IMN)Tj
2.1884 0 Td
(were)Tj
2.1203 0 Td
(included.)Tj
3.9401 0 Td
(We)Tj
1.6101 0 Td
(included)Tj
3.7077 0 Td
(studies)Tj
2.9877 0 Td
(of)Tj
1.0148 0 Td
(peo-)Tj
-35.5122 -1.3039 Td
(ple)Tj
1.4059 0 Td
(with)Tj
1.9956 0 Td
(biopsy)Tj
2.8346 0 Td
(proven)Tj
3.0444 0 Td
(IMN)Tj
2.1884 0 Td
(and)Tj
1.7291 0 Td
(nephrotic)Tj
4.1045 0 Td
(range)Tj
2.4605 0 Td
(proteinuria)Tj
4.7565 0 Td
(\(urinary)Tj
3.5319 0 Td
(protein)Tj
3.1578 0 Td
(excretion)Tj
/F12 1 Tf
0 Tc
3.9458 0 Td
(>)Tj
/F6 1 Tf
-0.004 Tc
(3.5)Tj
-35.155 -1.2982 Td
(g/24h\).)Tj
3.0557 0 Td
(Membranous)Tj
5.6125 0 Td
(nephropathy)Tj
5.3518 0 Td
(secondary)Tj
4.269 0 Td
(to)Tj
1.0261 0 Td
(autoimmune)Tj
5.3915 0 Td
(diseases,)Tj
3.6056 0 Td
(cancer,)Tj
3.0671 0 Td
(infections)Tj
-31.3793 -1.2983 Td
(\(including)Tj
4.3823 0 Td
(B)Tj
0.7993 0 Td
(and)Tj
1.7292 0 Td
(C)Tj
0.8844 0 Td
(hepatitis\))Tj
3.9514 0 Td
(and)Tj
1.7348 0 Td
(drugs,)Tj
2.6929 0 Td
(or)Tj
1.0999 0 Td
(atypical)Tj
3.2938 0 Td
(membranous)Tj
5.5389 0 Td
(nephropathy)Tj
5.3517 0 Td
(were)Tj
2.1204 0 Td
(excluded)Tj
-33.579 -1.3039 Td
(from)Tj
2.2053 0 Td
(our)Tj
1.6271 0 Td
(review.)Tj
-2.6362 -1.2983 Td
(Type)Tj
2.228 0 Td
(of)Tj
1.0148 0 Td
(interventions:)Tj
5.7656 0 Td
(We)Tj
1.6101 0 Td
(included)Tj
3.7077 0 Td
(any)Tj
1.6611 0 Td
(treatment)Tj
4.1329 0 Td
(expected)Tj
3.7247 0 Td
(to)Tj
1.0261 0 Td
(primarily)Tj
3.9685 0 Td
(act)Tj
1.3719 0 Td
(via)Tj
1.3777 0 Td
(an)Tj
1.2018 0 Td
(immu-)Tj
-33.9871 -1.2982 Td
(nosuppressive)Tj
5.862 0 Td
(effect.)Tj
2.5851 0 Td
(Agents)Tj
3.0047 0 Td
(without)Tj
3.3279 0 Td
(clear)Tj
2.1203 0 Td
(mechanism)Tj
4.8415 0 Td
(of)Tj
1.0148 0 Td
(immunosuppressive)Tj
8.2998 0 Td
(effects)Tj
2.7213 0 Td
(\(such)Tj
2.4037 0 Td
(as)Tj
-36.1811 -1.304 Td
(traditional)Tj
4.4163 0 Td
(Chinese)Tj
3.4356 0 Td
(medicine\))Tj
4.2632 0 Td
(were)Tj
2.1204 0 Td
(excluded.)Tj
-13.0393 -1.2982 Td
(Comparators:)Tj
5.7316 0 Td
(Different)Tj
3.8664 0 Td
(immunosuppressive)Tj
8.2941 0 Td
(treatments)Tj
4.4958 0 Td
(were)Tj
2.1203 0 Td
(compared)Tj
4.2462 0 Td
(with)Tj
1.9956 0 Td
(each)Tj
2.0296 0 Td
(other)Tj
2.3471 0 Td
(or)Tj
-36.3229 -1.2983 Td
(with)Tj
1.9955 0 Td
(non-immunosuppressiv)Tj
9.6094 0 Td
(e)Tj
0.6406 0 Td
(treatment)Tj
4.1386 0 Td
(\(placebo,)Tj
3.8438 0 Td
(renin)Tj
2.3754 0 Td
(angiotensin)Tj
4.8925 0 Td
(system)Tj
2.9367 0 Td
(blockers)Tj
3.5546 0 Td
(or)Tj
1.0999 0 Td
(other)Tj
-35.087 -1.2983 Td
(supportive)Tj
4.4617 0 Td
(therapies\).)Tj
4.4106 0 Td
(We)Tj
1.6101 0 Td
(excluded)Tj
3.7871 0 Td
(the)Tj
1.4683 0 Td
(trials)Tj
2.1997 0 Td
(with)Tj
1.9956 0 Td
(more)Tj
2.3414 0 Td
(than)Tj
2.0295 0 Td
(two)Tj
1.7065 0 Td
(immunosuppressive)Tj
8.2941 0 Td
(agents)Tj
-34.3046 -1.3039 Td
(in)Tj
1.0318 0 Td
(one)Tj
1.7007 0 Td
(arm)Tj
1.8482 0 Td
(\(except)Tj
3.1068 0 Td
(steroids\))Tj
3.6793 0 Td
(due)Tj
1.7008 0 Td
(to)Tj
1.0261 0 Td
(difficulty)Tj
3.8041 0 Td
(in)Tj
1.0375 0 Td
(differentiating)Tj
5.9357 0 Td
(the)Tj
1.4683 0 Td
(treatment)Tj
4.1386 0 Td
(effects)Tj
2.7269 0 Td
(as)Tj
1.0148 0 Td
(a)Tj
0.6519 0 Td
(result)Tj
-34.8715 -1.2982 Td
(of)Tj
1.0147 0 Td
(the)Tj
1.4684 0 Td
(combined)Tj
4.2463 0 Td
(effect)Tj
2.364 0 Td
(or)Tj
1.0942 0 Td
(the)Tj
1.474 0 Td
(sum)Tj
1.9276 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4683 0 Td
(monotherapy)Tj
5.6296 0 Td
(effect.)Tj
2.5908 0 Td
(Studies)Tj
3.1011 0 Td
(that)Tj
1.7745 0 Td
(assessed)Tj
3.4752 0 Td
(the)Tj
1.4684 0 Td
(same)Tj
-34.1119 -1.2983 Td
(immunosuppressive)Tj
8.2941 0 Td
(agents)Tj
2.7496 0 Td
(with)Tj
1.9955 0 Td
(different)Tj
3.6567 0 Td
(doses)Tj
2.4038 0 Td
(in)Tj
1.0318 0 Td
(different)Tj
3.6566 0 Td
(arms)Tj
2.2054 0 Td
(but)Tj
1.5534 0 Td
(no)Tj
1.2755 0 Td
(other)Tj
2.3471 0 Td
(comparator)Tj
-31.1695 -1.3039 Td
(were)Tj
2.1203 0 Td
(excluded.)Tj
4.0138 0 Td
(Trials)Tj
2.5058 0 Td
(with)Tj
2.0012 0 Td
(a)Tj
0.652 0 Td
(follow-up)Tj
4.0932 0 Td
(of)Tj
1.0148 0 Td
(less)Tj
1.6157 0 Td
(than)Tj
2.024 0 Td
(6)Tj
0.6973 0 Td
(months)Tj
3.2825 0 Td
(were)Tj
2.1203 0 Td
(excluded,)Tj
4.0138 0 Td
(as)Tj
1.0148 0 Td
(were)Tj
2.1203 0 Td
(cross-over)Tj
-33.2898 -1.2983 Td
(trials.)Tj
2.4207 0 Td
(The)Tj
1.7858 0 Td
(abstracts)Tj
3.7077 0 Td
(were)Tj
2.1203 0 Td
(initially)Tj
3.2485 0 Td
(screened)Tj
3.7247 0 Td
(by)Tj
1.1792 0 Td
(two)Tj
1.7121 0 Td
(researchers)Tj
4.7112 0 Td
(\(SR)Tj
1.6554 0 Td
(and)Tj
1.7291 0 Td
(LX\).)Tj
1.9786 0 Td
(Disagreements)Tj
-29.9733 -1.2982 Td
(were)Tj
2.1203 0 Td
(resolved)Tj
3.5376 0 Td
(through)Tj
3.4412 0 Td
(discussions)Tj
4.7338 0 Td
(\(SR,)Tj
1.8822 0 Td
(LX,)Tj
1.6384 0 Td
(DH)Tj
1.7235 0 Td
(and)Tj
1.7291 0 Td
(GL\).)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 448.5543 cm
BT
/F0 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Data)Tj
2.3102 0 Td
(extraction)Tj
4.5024 0 Td
(and)Tj
1.8662 0 Td
(quality)Tj
3.0708 0 Td
(assessment)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 431.5464 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(Data)Tj
2.1203 0 Td
(extraction)Tj
4.2576 0 Td
(was)Tj
1.7007 0 Td
(undertaken)Tj
4.8189 0 Td
(independently)Tj
5.9754 0 Td
(by)Tj
1.1792 0 Td
(2)Tj
0.6973 0 Td
(investigators)Tj
5.2781 0 Td
(\(SR)Tj
1.6554 0 Td
(and)Tj
1.7291 0 Td
(LX\))Tj
1.7518 0 Td
(using)Tj
2.3925 0 Td
(a)Tj
0.6519 0 Td
(stan-)Tj
-34.2082 -1.2982 Td
(dardized)Tj
3.7133 0 Td
(electronic)Tj
4.1499 0 Td
(form.)Tj
2.4321 0 Td
(Disagreements)Tj
6.1512 0 Td
(in)Tj
1.0374 0 Td
(abstracted)Tj
4.2973 0 Td
(data)Tj
1.9162 0 Td
(were)Tj
2.1203 0 Td
(resolved)Tj
3.5377 0 Td
(by)Tj
1.1792 0 Td
(a)Tj
0.6519 0 Td
(third)Tj
2.2167 0 Td
(investiga-)Tj
-33.4032 -1.3039 Td
(tor)Tj
1.3946 0 Td
(\(DH\).)Tj
2.6305 0 Td
(The)Tj
1.7802 0 Td
(abstracted)Tj
4.3029 0 Td
(data)Tj
1.9106 0 Td
(included)Tj
3.7133 0 Td
(baseline)Tj
3.4299 0 Td
(characteristics)Tj
5.9074 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4683 0 Td
(participants)Tj
4.955 0 Td
(such)Tj
2.0636 0 Td
(as)Tj
1.0148 0 Td
(age,)Tj
-35.5859 -1.2983 Td
(sex,)Tj
1.6951 0 Td
(serum)Tj
2.7212 0 Td
(creatinine,)Tj
4.4504 0 Td
(serum)Tj
2.7269 0 Td
(albumin)Tj
3.5659 0 Td
(and)Tj
1.7348 0 Td
(proteinuria)Tj
4.7509 0 Td
(value.)Tj
2.5285 0 Td
(The)Tj
1.7858 0 Td
(main)Tj
2.2904 0 Td
(outcomes)Tj
4.0875 0 Td
(included)Tj
3.7077 0 Td
(1\))Tj
-36.0451 -1.2983 Td
(the)Tj
1.4683 0 Td
(composite)Tj
4.3426 0 Td
(of)Tj
1.0148 0 Td
(all-cause)Tj
3.668 0 Td
(mortality)Tj
3.9175 0 Td
(or)Tj
1.0998 0 Td
(ESKD)Tj
2.6703 0 Td
(\(defined)Tj
3.5659 0 Td
(as)Tj
1.0148 0 Td
(start)Tj
1.9843 0 Td
(of)Tj
1.0147 0 Td
(dialysis)Tj
3.1408 0 Td
(or)Tj
1.0999 0 Td
(renal)Tj
2.2393 0 Td
(transplanta-)Tj
-32.241 -1.3039 Td
(tion\);)Tj
2.4037 0 Td
(2\))Tj
1.0375 0 Td
(complete)Tj
3.8778 0 Td
(or)Tj
1.0998 0 Td
(partial)Tj
2.7893 0 Td
(remission)Tj
4.1442 0 Td
(\(defined)Tj
3.566 0 Td
(by)Tj
1.1792 0 Td
(the)Tj
1.474 0 Td
(authors)Tj
3.2428 0 Td
(in)Tj
1.0375 0 Td
(each)Tj
2.0295 0 Td
(study\);)Tj
2.9537 0 Td
(3\))Tj
1.0375 0 Td
(withdrawal)Tj
-31.8725 -1.2982 Td
(due)Tj
1.6951 0 Td
(to)Tj
1.0261 0 Td
(the)Tj
1.474 0 Td
(drug)Tj
2.109 0 Td
(related)Tj
2.9423 0 Td
(toxicity.)Tj
3.4299 0 Td
(Other)Tj
2.5852 0 Td
(outcomes)Tj
4.0875 0 Td
(included)Tj
3.7134 0 Td
(adverse)Tj
3.2144 0 Td
(reactions)Tj
3.8551 0 Td
(such)Tj
2.0637 0 Td
(as)Tj
1.0147 0 Td
(infection,)Tj
-33.2104 -1.2983 Td
(bone)Tj
2.2053 0 Td
(marrow)Tj
3.4072 0 Td
(suppression,)Tj
5.2101 0 Td
(abnormal)Tj
4.0875 0 Td
(liver)Tj
1.9786 0 Td
(function,)Tj
3.8551 0 Td
(incidence)Tj
4.0762 0 Td
(of)Tj
1.0147 0 Td
(diabetes)Tj
3.4583 0 Td
(mellitus)Tj
3.4129 0 Td
(or)Tj
1.0942 0 Td
(hyper-)Tj
-33.8001 -1.3039 Td
(tension,)Tj
3.3958 0 Td
(or)Tj
1.0999 0 Td
(as)Tj
1.0148 0 Td
(defined)Tj
3.2258 0 Td
(by)Tj
1.1848 0 Td
(the)Tj
1.4684 0 Td
(study)Tj
2.3867 0 Td
(authors.)Tj
3.4753 0 Td
(Study)Tj
2.5058 0 Td
(quality)Tj
2.9537 0 Td
(was)Tj
1.6951 0 Td
(judged)Tj
2.9537 0 Td
(by)Tj
1.1792 0 Td
(the)Tj
1.4683 0 Td
(Jadad)Tj
2.4718 0 Td
(score[)Tj
0.83 0.64 0.02 0 k
(6)Tj
0 g
(])Tj
3.4639 0 Td
(and)Tj
-35.943 -1.2983 Td
(Cochrane)Tj
4.1158 0 Td
(Collaboration)Tj
5.76 0 Td
(tool[)Tj
0.83 0.64 0.02 0 k
(7)Tj
0 g
(])Tj
2.931 0 Td
(for)Tj
1.389 0 Td
(assessing)Tj
3.7984 0 Td
(the)Tj
1.474 0 Td
(risk)Tj
1.7121 0 Td
(of)Tj
1.0148 0 Td
(bias.)Tj
2.0182 0 Td
(We)Tj
1.6044 0 Td
(considered)Tj
4.6035 0 Td
(the)Tj
1.4683 0 Td
(study)Tj
2.3924 0 Td
(of)Tj
1.0148 0 Td
(low-)Tj
-35.2967 -1.2983 Td
(quality)Tj
2.9536 0 Td
(if)Tj
0.7767 0 Td
(the)Tj
1.4684 0 Td
(Jadad)Tj
2.4718 0 Td
(score)Tj
2.3073 0 Td
(was)Tj
1.7008 0 Td
(less)Tj
1.6101 0 Td
(than)Tj
2.0296 0 Td
(3,)Tj
0.9184 0 Td
(or)Tj
1.0998 0 Td
(higher-quality)Tj
5.8904 0 Td
(if)Tj
0.771 0 Td
(the)Tj
1.4683 0 Td
(Jadad)Tj
2.4775 0 Td
(score)Tj
2.3017 0 Td
(was)Tj
1.7008 0 Td
(more)Tj
2.3414 0 Td
(than)Tj
2.0296 0 Td
(or)Tj
-36.3172 -1.2982 Td
(equal)Tj
2.3584 0 Td
(to)Tj
1.0261 0 Td
(3.)Tj
0.9184 0 Td
(The)Tj
1.7802 0 Td
(risk)Tj
1.7177 0 Td
(of)Tj
1.0148 0 Td
(bias)Tj
1.7915 0 Td
(assessment)Tj
4.6091 0 Td
(included)Tj
3.7134 0 Td
(random)Tj
3.4299 0 Td
(sequence)Tj
3.8551 0 Td
(generation,)Tj
4.7338 0 Td
(allocation)Tj
4.1329 0 Td
(con-)Tj
-35.0813 -1.3039 Td
(cealment,)Tj
4.0591 0 Td
(blinding)Tj
3.6 0 Td
(of)Tj
1.0148 0 Td
(participants)Tj
4.9549 0 Td
(and)Tj
1.7348 0 Td
(personnel,)Tj
4.388 0 Td
(blinding)Tj
3.6 0 Td
(of)Tj
1.0148 0 Td
(outcome)Tj
3.7247 0 Td
(assessment,)Tj
4.8359 0 Td
(incomplete)Tj
-32.927 -1.2983 Td
(outcome)Tj
3.7247 0 Td
(data,)Tj
2.1373 0 Td
(selective)Tj
3.5432 0 Td
(reporting)Tj
3.9912 0 Td
(and)Tj
1.7291 0 Td
(other)Tj
2.3471 0 Td
(bias[)Tj
0.83 0.64 0.02 0 k
(8)Tj
0 g
(].)Tj
3.1691 0 Td
(We)Tj
1.6101 0 Td
(summarized)Tj
5.1873 0 Td
(both)Tj
2.058 0 Td
(individual)Tj
4.2859 0 Td
(and)Tj
-33.783 -1.2983 Td
(aggregate)Tj
3.9968 0 Td
(risk)Tj
1.7178 0 Td
(of)Tj
1.0148 0 Td
(bias)Tj
1.7914 0 Td
(data)Tj
1.9106 0 Td
(for)Tj
1.3889 0 Td
(the)Tj
1.4684 0 Td
(included)Tj
3.7133 0 Td
(studies.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 217.0204 cm
BT
/F0 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Data)Tj
2.3102 0 Td
(synthesis)Tj
4.3418 0 Td
(and)Tj
1.8614 0 Td
(statistical)Tj
4.2851 0 Td
(analysis)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 200.0125 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(We)Tj
1.61 0 Td
(use)Tj
1.5307 0 Td
(STATA)Tj
3.2882 0 Td
(\(version)Tj
3.4922 0 Td
(14.0\))Tj
2.2111 0 Td
(to)Tj
1.0261 0 Td
(perform)Tj
3.5149 0 Td
(network)Tj
3.549 0 Td
(meta-analysis)Tj
5.6522 0 Td
(with)Tj
2.0013 0 Td
(a)Tj
0.6519 0 Td
(random-effects)Tj
-28.5276 -1.3039 Td
(mixed-treatment)Tj
6.9901 0 Td
(comparisons)Tj
5.3348 0 Td
(model)Tj
2.7439 0 Td
(for)Tj
1.389 0 Td
(multi-armed)Tj
5.3008 0 Td
(trials)Tj
2.1996 0 Td
(within)Tj
2.812 0 Td
(the)Tj
1.474 0 Td
(frequency)Tj
4.1839 0 Td
(probability)Tj
-32.4281 -1.2982 Td
(method)Tj
3.3221 0 Td
(on)Tj
1.2756 0 Td
(the)Tj
1.4684 0 Td
(effects)Tj
2.7269 0 Td
(of)Tj
1.0148 0 Td
(main)Tj
2.2903 0 Td
(outcomes.)Tj
4.3143 0 Td
(Odds)Tj
2.3811 0 Td
(ratios)Tj
2.4605 0 Td
(\(OR\))Tj
2.2677 0 Td
(and)Tj
1.7291 0 Td
(their)Tj
2.109 0 Td
(95%)Tj
1.9275 0 Td
(confidence)Tj
4.6035 0 Td
(intervals)Tj
-33.8908 -1.2983 Td
(\(CI\))Tj
1.9048 0 Td
(were)Tj
2.1203 0 Td
(used)Tj
2.058 0 Td
(to)Tj
1.0261 0 Td
(compare)Tj
3.719 0 Td
(treatment)Tj
4.1329 0 Td
(effects)Tj
2.7269 0 Td
(for)Tj
1.3833 0 Td
(each)Tj
2.0296 0 Td
(dichotomous)Tj
5.4935 0 Td
(outcome.)Tj
3.9515 0 Td
(To)Tj
1.3379 0 Td
(summarize)Tj
-31.8838 -1.2983 Td
(the)Tj
1.4683 0 Td
(effectiveness)Tj
5.2044 0 Td
(and)Tj
1.7291 0 Td
(tolerance)Tj
3.8948 0 Td
(of)Tj
1.0148 0 Td
(all)Tj
1.1508 0 Td
(treatments,)Tj
4.7168 0 Td
(we)Tj
1.3323 0 Td
(also)Tj
1.7688 0 Td
(calculated)Tj
4.2009 0 Td
(the)Tj
1.4684 0 Td
(surface)Tj
3.05 0 Td
(under)Tj
2.6192 0 Td
(the)Tj
-33.6186 -1.3039 Td
(cumulative)Tj
4.6431 0 Td
(ranking)Tj
3.3505 0 Td
(curve)Tj
2.4208 0 Td
(\(SUCRA\).)Tj
-9.2182 -1.2982 Td
(The)Tj
1.7858 0 Td
(heterogeneity)Tj
5.6522 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4684 0 Td
(included)Tj
3.7133 0 Td
(studies)Tj
2.9877 0 Td
(was)Tj
1.6951 0 Td
(large,)Tj
2.3868 0 Td
(and)Tj
1.7291 0 Td
(it)Tj
0.788 0 Td
(is)Tj
0.8448 0 Td
(unavoidable.)Tj
5.3234 0 Td
(So)Tj
1.2019 0 Td
(we)Tj
1.3322 0 Td
(perform)Tj
3.515 0 Td
(a)Tj
-36.6347 -1.2983 Td
(consistency)Tj
4.8358 0 Td
(test)Tj
1.5988 0 Td
(to)Tj
1.0261 0 Td
(differences)Tj
4.5694 0 Td
(between)Tj
3.5263 0 Td
(direct)Tj
2.5285 0 Td
(and)Tj
1.7348 0 Td
(various)Tj
3.1407 0 Td
(indirect)Tj
3.3449 0 Td
(comparisons)Tj
5.3404 0 Td
(by)Tj
1.1792 0 Td
(the)Tj
1.4684 0 Td
(node-)Tj
-34.2933 -1.3039 Td
(splitting)Tj
3.4865 0 Td
(approach)Tj
3.9515 0 Td
(for)Tj
1.389 0 Td
(the)Tj
1.4683 0 Td
(main)Tj
2.2904 0 Td
(outcomes.)Tj
4.3143 0 Td
(The)Tj
/F13 1 Tf
1.7801 0 Td
[()]TJ
/F6 1 Tf
0.6974 0 Td
(value)Tj
2.3074 0 Td
(was)Tj
1.6951 0 Td
(calculated)Tj
4.2065 0 Td
(by)Tj
1.1793 0 Td
(the)Tj
1.474 0 Td
(node-splitting)Tj
-30.2398 -1.2983 Td
(method,)Tj
3.5489 0 Td
(which)Tj
2.6475 0 Td
(separated)Tj
4.0139 0 Td
(evidence)Tj
3.7133 0 Td
(on)Tj
1.2756 0 Td
(a)Tj
0.652 0 Td
(particular)Tj
4.1102 0 Td
(comparison)Tj
4.9776 0 Td
(into)Tj
1.8368 0 Td
(direct)Tj
2.5342 0 Td
(and)Tj
1.7291 0 Td
(indirect)Tj
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 107.1496 23.6976 re
W* n
q
107.0929 0 0 23.6409 36 741.3165 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 350.5322 745.7952 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(Immunos)Tj
4.0535 0 Td
(uppressive)Tj
4.9678 0 Td
(treatments)Tj
4.8756 0 Td
(for)Tj
1.3677 0 Td
(IMN:)Tj
2.3103 0 Td
(A)Tj
0.8787 0 Td
(network)Tj
3.6638 0 Td
(meta-ana)Tj
4.1528 0 Td
(lysis)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
0.83 0.64 0.02 0 k
81.5811 34.9228 m
237.8835 34.9228 l
h
f*
0 g
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(ONE)Tj
2.3669 0 Td
(|)Tj
0.83 0.64 0.02 0 k
0.4748 0 Td
(https://doi.or)Tj
5.4142 0 Td
(g/10.137)Tj
3.8198 0 Td
(1/journal.po)Tj
5.1236 0 Td
(ne.01843)Tj
4.089 0 Td
(98)Tj
0 g
2.0906 0 Td
(September)Tj
5.0386 0 Td
(12,)Tj
1.5874 0 Td
(2017)Tj
32.2798 0 Td
(3)Tj
0.7654 0 Td
(/)Tj
ET
endstream
endobj
50 0 obj
<>stream
endstream
endobj
51 0 obj
<>stream
endstream
endobj
52 0 obj
<>stream
endstream
endobj
53 0 obj
<>stream
endstream
endobj
54 0 obj
<>stream
endstream
endobj
55 0 obj
<>stream
BT
66.402 0 Td
(15)Tj
ET
Q
endstream
endobj
56 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 12 0 R/Annots 58 0 R/Contents 59 0 R/TrimBox[0 0 612 792]>>
endobj
57 0 obj
<>stream
x\T)~[DAQ `- 6*X)%l,`#[3ܚ;sw.@fRT&$@C! 4
pxĢ @H #Y,LNOO {t@Hڍ7}||"##`0ʊ%!$ @uCd={v媪O۵k7hР i<&$@C! W5]]ݡCիupСØ1cLLLH$R\X$ @H `ʕ+W6onݺ
6lݺuFFFv\.aBH 4pUӧwW